Throughout the years, polling has consistently shown that one of Democrats' most popular policies has been allowing Medicare to negotiate lower prescription drug prices for beneficiaries.
In fact, recent polling by the Kaiser Family Foundation shows that even 77 percent of Republican voters support allowing the government to negotiate for lower drug prices, which means a push by Republicans to repeal the government's power to do so would be unpopular even among their base.
Nonetheless, Axios reported Tuesday that many congressional Republicans are going full steam ahead on repealing the portion of the Inflation Reduction Act that gives the government power to haggle with pharmaceutical companies on specific drugs.
Rep. Buddy Carter (R-GA), for instance, described the provision as "the worst legislation I've ever witnessed in 10 years in Congress and 10 years in the state legislature" and said he was "absolutely" all-in on repeal.
ALSO READ: Corporate media keeps hiding the truth about madman Donald Trump
Sen. Thom Tillis (R-NC), meanwhile, said he was "100 percent" in favor of repealing the negotiating powers, and that he also wanted to scrutinize other parts of the law to ensure they have "a positive impact on business."
But the problem Republicans have, noted Axios, is that they have no alternative plan to repealing a provision that will save their own constituents significant money on medication.
"I would try to remove that and replace it, but I can't tell you the exact, you know, what it would be yet," Sen. Mike Crapo (R-ID) told the publication.
